Jason Stein, M.D.
Director and Co-Founder
Dr. Stein is founder and co-chairman of Actin Biomed, a healthcare investment firm advancing the discovery and development of novel treatments for unmet medical needs. He is also a co-founder of Foresight Biotherapeutics, an Actin company that is developing novel ocular and otic therapies.
Dr. Stein received his undergraduate degree from the University of Michigan and his medical degree from Saba University.
Michael Weiser, M.D., Ph.D.
Director and Co-Founder
Dr. Weiser is founder and co-chairman of Actin Biomed, a healthcare investment firm advancing the discovery and development of novel treatments for unmet medical needs. He is also a co-founder of Foresight Biotherapeutics, an Actin company that is developing novel ocular and otic therapies.
Dr. Weiser currently serves on the boards of directors of several publicly traded and privately held companies.
Dr. Weiser completed his doctorate in molecular neurobiology at Cornell University Medical College, received a medical degree from New York University School of Medicine and a bachelor of arts in psychology from University of Vermont.